<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01402869</url>
  </required_header>
  <id_info>
    <org_study_id>5110172</org_study_id>
    <nct_id>NCT01402869</nct_id>
  </id_info>
  <brief_title>Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics</brief_title>
  <official_title>Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Prilocaine Versus Lidocaine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish and compare maximum methemoglobin blood levels and times to maximum
      methemoglobin blood levels following the administration of the injectable local anesthetics
      prilocaine and lidocaine when used for dental treatment in pediatric patients under general
      anesthesia. Patients will be randomized into three equal study groups. Two of the study
      groups will receive local anesthetic and the third group will not. Methemoglobin blood levels
      will be non-invasively monitored and recorded throughout dental treatment for all groups
      using a Masimo Radical-7 Pulse Co-Oximeter device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methemoglobin is an abnormal hemoglobin that is formed by the oxidation of one or more of the
      four heme groups of hemoglobin by oxygen and other exogenous oxidizing agents. The injectable
      local anesthetic prilocaine that is routinely used in the medical and dental professions is a
      well known inducer of methemoglobin. The injectable local anesthetic lidocaine has also been
      suggested to be associated with the development of methemoglobin; however, there is no direct
      evidence supporting these claims.

      The concern with methemoglobin is that it is a dose-dependent toxin. The oxidation of one of
      the iron groups from a ferrous state to a ferric state alters the molecular structure of the
      hemoglobin molecule and impairs its ability to bind oxygen. This ultimately results in less
      oxygen being delivered to peripheral tissues and less carbon dioxide being removed which can
      cause tissue hypoxia. A small amount (0-2%) of methemoglobin is normally present in the blood
      as a result of the oxidation of hemoglobin by the prototypical oxidant oxygen. However, when
      an individual is exposed to an exogenous oxidizing agent of sufficient dosage and potency,
      methemoglobin levels can rise above 2% and a person can develop what is known as acquired
      methemoglobinemia. Signs of cyanosis as a result of acquired methemoglobinemia usually become
      present when methemoglobin blood levels rise above 15%.

      Despite the injectable local anesthetic prilocaine being a well known inducer of
      methemoglobin and lidocaine being a speculated inducer, there are no documented studies or
      trials in the dental literature as to the extent of the amount of methemoglobin that is
      formed following the routine use of these injectable local anesthetics.

      This investigation will examine the peak blood levels of methemoglobin and the time to the
      peak levels of methemoglobin following the use of injectable prilocaine and lidocaine when
      used for dental treatment in pediatric patients under general anesthesia.

      This study population will consist of 90 patients, 3 to 6 years of age, scheduled to undergo
      comprehensive dental rehabilitation under general anesthesia at the Koppel Special Care
      Dentistry Center at Loma Linda University School of Dentistry. Following enrollment, subjects
      will be randomized into three equal study groups: 1) 4% prilocaine plain, 2) 2% lidocaine
      with 1:100,000 epinephrine, and 3) No local anesthetic. All subjects will have a Masimo
      Radical-7 pediatric, non-disposable, pulse co-oximeter sensor placed on the ring finger of
      the right hand following the induction of general anesthesia. The sensor will then be
      connected to a Radical-7 Pulse Co-Oximeter. The pulse co-oximeter will non-invasively monitor
      and record methemoglobin blood levels at 10 second intervals throughout dental treatment.
      Following a routine oral examination, radiographs, and prophylaxis, subjects assigned to
      Groups 1 and 2 will be administered local anesthetic for restorative dental treatment. Group
      1 subjects will receive 5mg/kg of 4% prilocaine plain and Group 2 subjects will receive
      2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine. Group 3 subjects will not receive local
      anesthetic. The time of local anesthetic administration and baseline methemoglobin blood
      levels will be recorded. Methemoglobin blood levels will be monitored and recorded throughout
      the completion of the dental treatment and during recovery from general anesthesia until
      subject movement precludes any further monitoring.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak Methemoglobin Blood Levels</measure>
    <time_frame>Measured at 10 second intervals during dental treatment for an average of 2 hours</time_frame>
    <description>The maximum percentage of methemoglobin in blood</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Peak Methemoglobin Blood Levels</measure>
    <time_frame>Measured at 10 second intervals during dental treatment for an average of 2 hours</time_frame>
    <description>The length of time between the administration of local anesthetic (Prilocaine and Lidocaine Groups) or start of restorative dental procedures (No local anesthetic Group) and the time at which the maximum methemoglobin blood level is observed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delta Methemoglobin Blood Level</measure>
    <time_frame>From administration of local anesthetic or start of restorative procedures to time at which maximum methemoglobin blood level was documented during dental treatment for an average of 2 hours</time_frame>
    <description>Change in percentage of methemoglobin in blood from baseline level to peak level</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Methemoglobinemia</condition>
  <arm_group>
    <arm_group_label>Prilocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 subjects will receive 5mg/kg of 4% prilocaine plain local anesthetic for restorative dental treatment under general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 subjects will receive 2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine local anesthetic for restorative dental treatment under general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No local anesthetic</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>30 subjects will not receive local anesthetic for dental treatment under general anesthesia-Negative control</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4% prilocaine plain</intervention_name>
    <description>5mg/kg via infiltration into multiple sites of the buccal mucosa of mouth 1 time prior to start of restorative dental treatment</description>
    <arm_group_label>Prilocaine</arm_group_label>
    <other_name>Citanest Plain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Lidocaine with 1:100,000 epinephrine</intervention_name>
    <description>2.5mg/kg via infiltration into multiple sites of buccal mucosa of mouth 1 time prior to restorative dental treatment</description>
    <arm_group_label>Lidocaine</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient scheduled to undergo comprehensive dental treatment under general anesthesia
             at the Koppel Special Care Dentistry Center at Loma Linda University School of
             Dentistry

          -  ASA I or II health status

          -  Age greater than 3 years but less than 6 years

          -  Weigh between 10kg and 25kg

        Exclusion Criteria:

          -  Patient not requiring restorative dental treatment

          -  Have a BMI less than the 5th percentile or greater than the 95th percentile for their
             age and gender
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lauren L Gutenberg, DDS</last_name>
    <role>Study Director</role>
    <affiliation>Loma Linda University Department of Pediatric Dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jung-Wei Chen, DDS, MS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Department of Pediatric Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University School of Dentistry Koppel Special Care Dentistry Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999 Nov;34(5):646-56. Review.</citation>
    <PMID>10533013</PMID>
  </reference>
  <reference>
    <citation>Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). 2004 Sep;83(5):265-73.</citation>
    <PMID>15342970</PMID>
  </reference>
  <reference>
    <citation>Umbreit J. Methemoglobin--it's not just blue: a concise review. Am J Hematol. 2007 Feb;82(2):134-44. Review.</citation>
    <PMID>16986127</PMID>
  </reference>
  <reference>
    <citation>Trapp L, Will J. Acquired methemoglobinemia revisited. Dent Clin North Am. 2010 Oct;54(4):665-75. doi: 10.1016/j.cden.2010.06.007. Epub 2010 Aug 7. Review.</citation>
    <PMID>20831930</PMID>
  </reference>
  <reference>
    <citation>Malamed SF. Local anesthetics: dentistry's most important drugs, clinical update 2006. J Calif Dent Assoc. 2006 Dec;34(12):971-6.</citation>
    <PMID>17260521</PMID>
  </reference>
  <reference>
    <citation>Budenz AW. Local anesthetics in dentistry: then and now. J Calif Dent Assoc. 2003 May;31(5):388-96. Review.</citation>
    <PMID>12839231</PMID>
  </reference>
  <reference>
    <citation>Moore PA, Hersh EV. Local anesthetics: pharmacology and toxicity. Dent Clin North Am. 2010 Oct;54(4):587-99. doi: 10.1016/j.cden.2010.06.015. Review.</citation>
    <PMID>20831923</PMID>
  </reference>
  <reference>
    <citation>Bader AM, Concepcion M, Hurley RJ, Arthur GR. Comparison of lidocaine and prilocaine for intravenous regional anesthesia. Anesthesiology. 1988 Sep;69(3):409-12.</citation>
    <PMID>3415022</PMID>
  </reference>
  <reference>
    <citation>Vasters FG, Eberhart LH, Koch T, Kranke P, Wulf H, Morin AM. Risk factors for prilocaine-induced methaemoglobinaemia following peripheral regional anaesthesia. Eur J Anaesthesiol. 2006 Sep;23(9):760-5. Epub 2006 May 24.</citation>
    <PMID>16723054</PMID>
  </reference>
  <reference>
    <citation>Soeding P, Deppe M, Gehring H. Pulse-oximetric measurement of prilocaine-induced methemoglobinemia in regional anesthesia. Anesth Analg. 2010 Oct;111(4):1065-8. doi: 10.1213/ANE.0b013e3181eb6239. Epub 2010 Aug 12.</citation>
    <PMID>20705783</PMID>
  </reference>
  <reference>
    <citation>Wilburn-Goo D, Lloyd LM. When patients become cyanotic: acquired methemoglobinemia. J Am Dent Assoc. 1999 Jun;130(6):826-31. Review.</citation>
    <PMID>10377640</PMID>
  </reference>
  <reference>
    <citation>Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg. 2009 Mar;108(3):837-45. doi: 10.1213/ane.0b013e318187c4b1.</citation>
    <PMID>19224791</PMID>
  </reference>
  <reference>
    <citation>Adams V, Marley J, McCarroll C. Prilocaine induced methaemoglobinaemia in a medically compromised patient. Was this an inevitable consequence of the dose administered? Br Dent J. 2007 Nov 24;203(10):585-7.</citation>
    <PMID>18037845</PMID>
  </reference>
  <reference>
    <citation>American Academy of Pediatric Dentistry. American Academy of Pediatric Dentistry 2010-2011 Definitions, Oral Health Policies, and Clinical Guidelines: Guidelines on use of local anesthetic for pediatric dental patients. Pediatr Dent 2010;32(6):156-61</citation>
  </reference>
  <reference>
    <citation>Yagiela, J. Injectable and topical local anesthetics. In: ADA/PDR guide to dental therapeutics. 5th Edition. Chicago: American Dental Association Publishing Co; 2009 p. 11-2</citation>
  </reference>
  <reference>
    <citation>Herdevall BM, Klinge B, Persson L, Huledal G, Abdel-Rehim M. Plasma levels of lidocaine, o-toluidine, and prilocaine after application of 8.5 g Oraqix in patients with generalized periodontitis: effect on blood methemoglobin and tolerability. Acta Odontol Scand. 2003 Aug;61(4):230-4.</citation>
    <PMID>14582591</PMID>
  </reference>
  <reference>
    <citation>Barker SJ, Curry J, Redford D, Morgan S. Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study. Anesthesiology. 2006 Nov;105(5):892-7. Erratum in: Anesthesiology. 2007 Nov;107(5):863.</citation>
    <PMID>17065881</PMID>
  </reference>
  <reference>
    <citation>Feiner JR, Bickler PE. Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia. Anesth Analg. 2010 Nov;111(5):1160-7. doi: 10.1213/ANE.0b013e3181f46da8. Epub 2010 Sep 14.</citation>
    <PMID>20841412</PMID>
  </reference>
  <reference>
    <citation>Feiner JR, Bickler PE, Mannheimer PD. Accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia. Anesth Analg. 2010 Jul;111(1):143-8. doi: 10.1213/ANE.0b013e3181c91bb6. Epub 2009 Dec 10.</citation>
    <PMID>20007731</PMID>
  </reference>
  <reference>
    <citation>Ash-Bernal R, Brophy GM, Kily D. Acquired methemoglobinemia in the clinical setting: an important health issue revealed. CME Zone Special Report 2006 Nov.</citation>
  </reference>
  <reference>
    <citation>Dentsply Pharmaceutical. 4% Citanest Plain Package Insert. York, PA.</citation>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2011</study_first_submitted>
  <study_first_submitted_qc>July 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2011</study_first_posted>
  <results_first_submitted>October 15, 2013</results_first_submitted>
  <results_first_submitted_qc>March 25, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 25, 2014</results_first_posted>
  <last_update_submitted>March 25, 2014</last_update_submitted>
  <last_update_submitted_qc>March 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Lauren GutenBerg</investigator_full_name>
    <investigator_title>Pediatric Dental Resident</investigator_title>
  </responsible_party>
  <keyword>Methemoglobin</keyword>
  <keyword>Methemoglobinemia</keyword>
  <keyword>Prilocaine</keyword>
  <keyword>Lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methemoglobinemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients that were greater than 3 years but less than 6 years of age that were scheduled to undergo comprehensive dental rehabilitation under general anesthesia at the Koppel Special Care Dentistry Center at Loma Linda University School of Dentistry were recruited for the study.</recruitment_details>
      <pre_assignment_details>Enrolled participants were excluded prior to group assignment if they had a body mass index (BMI) less than the 5th percentile or greater than the 95th percentile for their age and gender.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Prilocaine</title>
          <description>5mg/kg of 4% prilocaine plain administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
        </group>
        <group group_id="P2">
          <title>Lidocaine</title>
          <description>2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
        </group>
        <group group_id="P3">
          <title>No Local Anesthetic</title>
          <description>No local anesthetic was administered prior to restorative dental treatment-Negative control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Required Tooth Extraction</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>1 subject was withdrawn from the no local anesthetic group as the subject required 1 or more dental tooth extractions and required local anesthetic</population>
      <group_list>
        <group group_id="B1">
          <title>Prilocaine</title>
          <description>5mg/kg of 4% prilocaine plain administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
        </group>
        <group group_id="B2">
          <title>Lidocaine</title>
          <description>2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
        </group>
        <group group_id="B3">
          <title>No Local Anesthetic</title>
          <description>No local anesthetic was administered prior to restorative dental treatment-Negative control</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="90"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.97" spread="9.84"/>
                    <measurement group_id="B2" value="50.77" spread="10.19"/>
                    <measurement group_id="B3" value="50.63" spread="8.43"/>
                    <measurement group_id="B4" value="50.79" spread="9.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight Continuous</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.17" spread="2.94"/>
                    <measurement group_id="B2" value="17.24" spread="2.78"/>
                    <measurement group_id="B3" value="17.19" spread="2.96"/>
                    <measurement group_id="B4" value="17.20" spread="2.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA Health Classification</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>I-Healthy patients; no systemic disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II-Patients with mild, systemic disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index Numerical Value</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.62" spread="1.12"/>
                    <measurement group_id="B2" value="15.69" spread="1.08"/>
                    <measurement group_id="B3" value="15.60" spread="1.03"/>
                    <measurement group_id="B4" value="15.64" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index Percentile</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&gt;=5th and &lt;=35th percentiles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;35th and &lt;=65th percentiles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;65th and &lt;=95th percentiles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Methemoglobin Blood Level</title>
          <description>Methemoglobin blood level recorded non-invasively by the Masimo Radical-7 Pulse Co-Oximeter prior to the administration of local anesthetic or start of restorative dental procedures.</description>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.82" spread="0.39"/>
                    <measurement group_id="B2" value="0.85" spread="0.35"/>
                    <measurement group_id="B3" value="0.84" spread="0.43"/>
                    <measurement group_id="B4" value="0.83" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Peak Methemoglobin Blood Levels</title>
        <description>The maximum percentage of methemoglobin in blood</description>
        <time_frame>Measured at 10 second intervals during dental treatment for an average of 2 hours</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Prilocaine</title>
            <description>5mg/kg of 4% prilocaine plain administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
          </group>
          <group group_id="O3">
            <title>No Local Anesthetic</title>
            <description>No local anesthetic was administered prior to restorative dental treatment-Negative control</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Methemoglobin Blood Levels</title>
          <description>The maximum percentage of methemoglobin in blood</description>
          <population>Per protocol</population>
          <units>percentage of methemoglobin in blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.55" spread="1.22"/>
                    <measurement group_id="O2" value="1.63" spread="0.52"/>
                    <measurement group_id="O3" value="1.60" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis: There is no statistically significant difference in peak methemoglobin blood levels following the administration of prilocaine, lidocaine, or no local anesthetic in pre-cooperative children undergoing comprehensive dental rehabilitation under general anesthesia.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>LSD post hoc test was used for multiple group comparisons. P&lt;.05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>LSD post hoc test was used for multiple group comparisons.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>least significant difference post hoc</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>=.89</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Peak Methemoglobin Blood Levels</title>
        <description>The length of time between the administration of local anesthetic (Prilocaine and Lidocaine Groups) or start of restorative dental procedures (No local anesthetic Group) and the time at which the maximum methemoglobin blood level is observed.</description>
        <time_frame>Measured at 10 second intervals during dental treatment for an average of 2 hours</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Prilocaine</title>
            <description>5mg/kg of 4% prilocaine plain administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
          </group>
          <group group_id="O3">
            <title>No Local Anesthetic</title>
            <description>No local anesthetic was administered prior to restorative dental treatment-Negative control</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Peak Methemoglobin Blood Levels</title>
          <description>The length of time between the administration of local anesthetic (Prilocaine and Lidocaine Groups) or start of restorative dental procedures (No local anesthetic Group) and the time at which the maximum methemoglobin blood level is observed.</description>
          <population>per protocol</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.73" spread="23.78"/>
                    <measurement group_id="O2" value="57.50" spread="30.67"/>
                    <measurement group_id="O3" value="29.50" spread="20.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis: There is no statistically significant difference in the time frame to peak methemoglobin levels following the administration of prilocaine, lidocaine, or no local anesthetic in pre-cooperative children undergoing comprehensive dental rehabilitation under general anesthesia.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <method>ANOVA</method>
            <method_desc>LSD post hoc test was used for multiple group comparisons.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>=.43</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Delta Methemoglobin Blood Level</title>
        <description>Change in percentage of methemoglobin in blood from baseline level to peak level</description>
        <time_frame>From administration of local anesthetic or start of restorative procedures to time at which maximum methemoglobin blood level was documented during dental treatment for an average of 2 hours</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Prilocaine</title>
            <description>5mg/kg of 4% prilocaine plain administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
          </group>
          <group group_id="O3">
            <title>No Local Anesthetic</title>
            <description>No local anesthetic was administered prior to restorative dental treatment-Negative control</description>
          </group>
        </group_list>
        <measure>
          <title>Delta Methemoglobin Blood Level</title>
          <description>Change in percentage of methemoglobin in blood from baseline level to peak level</description>
          <population>Per protocol</population>
          <units>percentage of methemoglobin in blood</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.73" spread="1.23"/>
                    <measurement group_id="O2" value="0.78" spread="0.44"/>
                    <measurement group_id="O3" value="0.76" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis: There is no statistically significant difference in delta methemoglobin blood levels following the administration prilocaine, lidocaine, or no local anesthetic in pre-cooperative children undergoing comprehensive dental rehabilitation under general anesthesia.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>ANOVA</method>
            <method_desc>LSD post hoc test was used for multiple group comparisons.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>&lt;.001</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>LSD post hoc pairwise comparison</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power of 80</non_inferiority_desc>
            <p_value>=.92</p_value>
            <p_value_desc>P&lt;.05</p_value_desc>
            <method>Least significant difference post hoc</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Reported adverse events include those that occurred at or after the administration of local anesthetic in the Prilocaine and Lidocaine Groups or the start of restorative dental procedures in the No Local Anesthetic Group.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Prilocaine</title>
          <description>5mg/kg of 4% prilocaine plain administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
        </group>
        <group group_id="E2">
          <title>Lidocaine</title>
          <description>2.5mg/kg of 2% lidocaine with 1:100,000 epinephrine administered via infiltration into multiple sites of the buccal mucosa of the mouth 1 time prior to start of restorative dental treatment</description>
        </group>
        <group group_id="E3">
          <title>No Local Anesthetic</title>
          <description>No local anesthetic was administered prior to restorative dental treatment-Negative control</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Did not compare locals anesthetics with equivalent concentrations of epinephrine; unable to control length of time methemoglobin blood levels were monitored as all subjects varied in extent of restorative dental procedures needed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Lauren Gutenberg</name_or_title>
      <organization>Loma Linda University</organization>
      <phone>909-558-4690</phone>
      <email>lgutenberg@llu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

